Kaplan-Meier survival analysis showed that high expression of H2BC5, H2BC9, H2BC11, and H2BC21 correlated with a poor OS, DFS, and PFI of glioma patients (Figure 3B). The gene discussed is H2BC5; the disease is central nervous system cancer.